We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,858 results
  1. Alopecia areata-like pattern of baldness: the most recent update and the expansion of novel phenotype and genotype in the CTNNB1 gene

    Neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV) is a rare autosomal dominant genetic disorder caused by genetic...

    Aysan Moeinafshar, Sahand Tehrani Fateh, ... Mohammad-Reza Ghasemi in Neurological Sciences
    Article 28 June 2023
  2. Desmoplastic fibroma of the pediatric cranium with CTNNB1 mutation: case report and literature review

    Purpose

    Desmoplastic fibroma (DF) is an uncommon intermediate bone tumor rarely involving the skull with unidentified pathogenesis. We report the...

    **nyao Wang, Wenbin Guan, ... **aoqiang Wang in Child's Nervous System
    Article 18 April 2024
  3. A novel de novo truncating variant in a Hungarian patient with CTNNB1 neurodevelopmental disorder

    Purpose

    We aimed to elucidate the underlying disease in a Hungarian family, with only one affected family member, a 16-year-old male Hungarian...

    Nikoletta Nagy, Margit Pál, ... Márta Széll in BMC Pediatrics
    Article Open access 15 January 2024
  4. Identification of a novel de novo mutation in the CTNNB1 gene in an Iranian patient with intellectual disability

    CTNNB1 encodes for the β-catenin protein, a component of the cadherin adhesion complex, which regulates cell–cell adhesion and gene expression in the...

    Sepide Dashti, Shadab Salehpour, ... Mohammad Miryounesi in Neurological Sciences
    Article 31 January 2022
  5. CTNNB1 mutation-driven hybrid tumor: desmoid fibromatosis with an unusual associated epithelioid component arising in association with a neuromuscular choristoma

    CTNNB1 mutations play important roles in the development of soft tissue tumors, such as desmoid fibromatosis (DF), sinonasal tract angiofibroma,...

    Xuanxuan Zheng, **n He, ... Hongying Zhang in Virchows Archiv
    Article 06 January 2024
  6. Rare histologic transformation of a CTNNB1 (β-catenin) mutated prostate cancer with aggressive clinical course

    Background

    Catenin (Cadherin-Associated Protein), Beta 1 ( CTNNB1) genomic alterations are rare in prostate cancer (PCa). Gain-of-function mutations...

    Dilara Akhoundova, Stefanie Fischer, ... Mark A. Rubin in Diagnostic Pathology
    Article Open access 21 June 2024
  7. SNHG1 functions as a ceRNA in hypertrophic scar fibroblast proliferation and apoptosis through miR-320b/CTNNB1 axis

    Hypertrophic scar (HS) is a fibrotic disease caused by skin injury. Competing endogenous RNA (ceRNA) has been demonstrated to implicate in the...

    Qiaoling Li, Bowei Zhang, ... Lei Zhang in Archives of Dermatological Research
    Article 09 February 2023
  8. Spastic Diplegia and Visual Defects in CTNNB1 Gene Mutation: Genetic Mimic of Cerebral Palsy

    Arushi Gahlot Saini, Pradeep Kumar Gunasekaran, ... Vikas Bhatia in Indian Journal of Pediatrics
    Article 08 November 2023
  9. CTNNB1 polymorphism (rs121913407) in circulating tumor DNA (ctDNA) in Egyptian hepatocellular carcinoma patients

    Background

    Hepatocellular carcinoma (HCC) represents the sixth most common cancer worldwide and the fourth in Egypt. Persistent inflammation and...

    Marwa A. Abdel-Wahed, Eman Mohamed Abdel Rahman Amer, ... Safeya Hamdy Zakaria Hassan in Egyptian Liver Journal
    Article Open access 20 July 2022
  10. Recurrent CTNNB1 mutations in craniofacial osteomas

    Osteoma is a benign bone forming tumor predominantly arising on the surface of craniofacial bones. While the vast majority of osteomas develops...

    Daniel Baumhoer, Ruth Berthold, ... Wolfgang Hartmann in Modern Pathology
    Article Open access 01 November 2021
  11. Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia

    Background

    Inherited vitreoretinopathies arise as a consequence of congenital retinal vascularisation abnormalities. They represent a phenotypically...

    Rachel L. Taylor, Carla Sanjuro Soriano, ... Graeme C. Black in Orphanet Journal of Rare Diseases
    Article Open access 04 March 2022
  12. The m6A reading protein YTHDF3 potentiates tumorigenicity of cancer stem-like cells in ocular melanoma through facilitating CTNNB1 translation

    N 6 -methyladenosine (m 6 A) is the most universal internal RNA modification on messenger RNAs and regulates the fate and functions of m 6 A-modified...

    Yangfan Xu, **aoyu He, ... **anqun Fan in Oncogene
    Article 03 February 2022
  13. Targeted next-generation sequencing reveals activating CTNNB1 mutations in SMARCA4/BRG1-deficient sinonasal carcinomas: a report of two new cases and a brief review of the literature with an emphasis on histogenesis

    SMARCA4/BRG1 is a catalytic subunit of the SWItch/sucrose non-fermentable (SWI/SNF) complex and its inactivation is known to drive a variety of...

    Ming Zhao, Tianshi Ma, ... Minghua Ge in Virchows Archiv
    Article 18 November 2022
  14. Prognostic significance of CTNNB1 mutation in early stage endometrial carcinoma: a systematic review and meta-analysis

    Background

    In the last years, mutations in the exon 3 of CTNNB1 have emerged as a possible prognostic factor for recurrence in early stage...

    Antonio Travaglino, Antonio Raffone, ... Antonio Mollo in Archives of Gynecology and Obstetrics
    Article Open access 16 January 2022
  15. “Pure” hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms

    Hepatoid tumors (HTs) represent a rare group of neoplasms that are histologically similar to hepatocellular carcinoma but arise outside the liver....

    Paola Mattiolo, Andrea Mafficini, ... Claudio Luchini in Virchows Archiv
    Article Open access 31 March 2022
  16. Clinicopathological features and prognostic significance of CTNNB1 mutation in low-grade, early-stage endometrial endometrioid carcinoma

    Low-grade and early-stage endometrioid endometrial carcinomas (EECs) have an overall good prognosis but biomarkers identifying patients at risk of...

    Ignacio Ruz-Caracuel, Álvaro López-Janeiro, ... David Hardisson in Virchows Archiv
    Article Open access 21 August 2021
  17. Endometrial stromal tumor with whorling and GREB1::CTNNB1 fusion—a case report on a rare entity

    Michaela Kendall Bártů, Miroslava Flídrová, ... Pavel Dundr in Virchows Archiv
    Article 12 July 2024
  18. Clinicopathologic and molecular characterization of melanomas mutated for CTNNB1 and MAPK

    Wnt/β-catenin signaling plays crucial roles in melanocyte biology and may be implicated in melanoma progression. In this study, we retrospectively...

    Bénédicte Oulès, Samia Mourah, ... Maxime Battistella in Virchows Archiv
    Article 20 May 2021
  19. Loss of CTNNB1 exon 3 in sclerosing angiomatoid nodular transformation of the spleen

    Sclerosing angiomatoid nodular transformation (SANT) is a rare vascular lesion of the spleen. Although several hypotheses have been suggested, the...

    Sarp Uzun, Özge Özcan, ... Aytekin Akyol in Virchows Archiv
    Article 01 March 2021
  20. MEF2A transcriptionally upregulates the expression of ZEB2 and CTNNB1 in colorectal cancer to promote tumor progression

    Colorectal cancer (CRC) is one of the leading cancers worldwide, accounting for high morbidity and mortality. The mechanisms governing tumor growth...

    Qing **ao, Yaqi Gan, ... Gang Yin in Oncogene
    Article Open access 16 April 2021
Did you find what you were looking for? Share feedback.